← Leaderboards
Fred Mermelstein
Pear Tree Pharmaceuticals, Inc.
$221,484
Attributed
$221,484
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$221,484 · 1
By mechanism
R43$221,484 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Adjuvant Therapy”
- Lawrence Corey · Fred Hutchinson Cancer Center$265,384,749
- Norman Wolmark · Nsabp Foundation, Inc.$252,082,455
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$105,968,129
- David Heimbrook · Leidos Biomedical Research, Inc.$59,661,099
- Dan H. Barouch · Fred Hutchinson Cancer Center$58,263,037
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,263,037
Research focus
Adjuvant TherapyAdverse EffectsAgedAgingAnimalsAromatase InhibitorsAtrophicBacterial InfectionsBaseBlood ClotBlood CoagulationBlood FlowBreast Cancer TreatmentBurn InjuryCancer RecurrenceCancer SurvivorCancer TherapyChronicClinical DataClinical ResearchClinical TrialsColorectal CancerComplexAdjuvant